sponsored
PatientsVille.com Logo

PatientsVille

AMITIZA and MISOPROSTOL

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectAMITIZAMISOPROSTOL
HAEMORRHAGE0% 12.8%
ABORTION INCOMPLETE0% 12.7%
ANAEMIA0.9% 4.8%
PREGNANCY0% 4.8%
NAUSEA4.3% 2.5%
DYSPNOEA4.3% 0.9%
PAIN2.6% 3.6%
DIARRHOEA3% 1.1%
MUSCLE SPASMS1.1% 3%
DIZZINESS2.5% 2.8%
CONSTIPATION2.8% 0.4%
MENORRHAGIA0% 2.8%
DRUG INEFFECTIVE2.7% 1.5%
FATIGUE2.7% 1.1%
HEADACHE2.5% 1%
VOMITING2.1% 2.4%
PYREXIA1.3% 2.4%
ABDOMINAL PAIN1.5% 2.3%
FALL2% 0.4%
ASTHENIA1.6% 1%
MALAISE1.6% 0.7%
SYNCOPE0.6% 1.6%
CHEST DISCOMFORT1.5% 0%
DEPRESSION1.4% 0.5%
ANXIETY1.4% 0.5%
WEIGHT DECREASED1.4% 0.4%
CHEST PAIN1.4% 0.4%
INSOMNIA1.4% 0.4%
ENDOMETRITIS0% 1.4%
DRUG EXPOSURE DURING PREGNANCY0% 1.3%
FEELING ABNORMAL1.3% 0%
PNEUMONIA1.2% 0.6%
PAIN IN EXTREMITY1.2% 0.5%
ARTHRALGIA1.2% 0.5%
DECREASED APPETITE1.2% 0%
OFF LABEL USE1.1% 0.7%
BACK PAIN1.1% 0.5%
GAIT DISTURBANCE1.1% 0%
PRURITUS1% 0.4%
RASH1% 0.4%
CONDITION AGGRAVATED1% 0.4%
TREMOR1% 0.3%
ABDOMINAL PAIN UPPER1% 0.3%
SOMNOLENCE1% 0%
ABDOMINAL DISTENSION1% 0%
FOETAL EXPOSURE DURING PREGNANCY0% 1%
CHILLS0.5% 0.9%
COUGH0.9% 0.3%
DEATH0.9% 0.3%
DEHYDRATION0.9% 0.3%
OEDEMA PERIPHERAL0.9% 0.3%
INFECTION0% 0.9%
WEIGHT INCREASED0.9% 0%
DRUG DOSE OMISSION0.9% 0%
HYPOTENSION0.6% 0.8%
HYPERTENSION0.8% 0.6%
URINARY TRACT INFECTION0.8% 0.4%
HYPERHIDROSIS0.8% 0.3%
MATERNAL EXPOSURE DURING PREGNANCY0% 0.8%
LOSS OF CONSCIOUSNESS0.7% 0.5%
HYPOAESTHESIA0.7% 0.5%
ABDOMINAL DISCOMFORT0.7% 0.3%
PARAESTHESIA0.7% 0.3%
PALPITATIONS0.7% 0%
MYALGIA0.7% 0%
MEMORY IMPAIRMENT0.7% 0%
GASTROOESOPHAGEAL REFLUX DISEASE0.6% 0.3%
EXPOSURE DURING PREGNANCY0% 0.6%
VAGINAL HAEMORRHAGE0% 0.6%
TACHYCARDIA0% 0.6%
FLATULENCE0.6% 0%
DYSPEPSIA0.6% 0%
PERIPHERAL SWELLING0.6% 0%
CHRONIC KIDNEY DISEASE0.6% 0%
BLOOD GLUCOSE INCREASED0.6% 0%
RENAL FAILURE0.6% 0%
MUSCULAR WEAKNESS0.6% 0%
BLOOD PRESSURE INCREASED0.6% 0%
INJECTION SITE PAIN0.6% 0%
SEPSIS0.4% 0.5%
DRUG HYPERSENSITIVITY0.4% 0.5%
ASTHMA0.5% 0.3%
INCORRECT DOSE ADMINISTERED0.5% 0.3%
ALOPECIA0.5% 0.3%
PRODUCT USE ISSUE0.5% 0.3%
CONTUSION0.5% 0.3%
DYSPHAGIA0.5% 0%
CONFUSIONAL STATE0.5% 0%
NASOPHARYNGITIS0.5% 0%
DRY MOUTH0.5% 0%
MIGRAINE0.5% 0%
HEART RATE INCREASED0.5% 0%
ACUTE KIDNEY INJURY0.5% 0%
BALANCE DISORDER0.5% 0%
BRONCHITIS0.5% 0%
RHEUMATOID ARTHRITIS0% 0.5%
UNEVALUABLE EVENT0.5% 0%
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION0% 0.5%
SINUSITIS0.5% 0%
PELVIC PAIN0% 0.5%
IRRITABLE BOWEL SYNDROME0.5% 0%
HYPERSENSITIVITY0.4% 0.4%
SWELLING0.4% 0.3%
HALLUCINATION0.4% 0%
CEREBROVASCULAR ACCIDENT0.4% 0%
CARDIAC ARREST0% 0.4%
CAESAREAN SECTION0% 0.4%
ABORTION INDUCED0% 0.4%
PELVIC INFLAMMATORY DISEASE0% 0.4%
PRODUCT USE IN UNAPPROVED INDICATION0% 0.4%
HAEMOGLOBIN DECREASED0% 0.4%
BLOOD PRESSURE DECREASED0.4% 0%
ECTOPIC PREGNANCY0% 0.4%
DRUG EFFECT DECREASED0.4% 0%
JOINT SWELLING0.4% 0%
MULTIPLE SCLEROSIS RELAPSE0.4% 0%
VISION BLURRED0.4% 0%
GASTROINTESTINAL HAEMORRHAGE0.4% 0%
HYPOKALAEMIA0.4% 0%
FLUSHING0.4% 0%
ERYTHEMA0.4% 0%
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION0.4% 0%
ARTHRITIS0% 0.3%
UTERINE RUPTURE0% 0.3%
THROMBOSIS0% 0.3%
MYOCARDIAL INFARCTION0% 0.3%
FOETAL DEATH0% 0.3%
DRUG INTERACTION0% 0.3%
WHITE BLOOD CELL COUNT INCREASED0% 0.3%
METRORRHAGIA0% 0.3%
UTERINE HAEMORRHAGE0% 0.3%
OSTEOARTHRITIS0% 0.3%
MICROGNATHIA0% 0.3%
MATERNAL DRUGS AFFECTING FOETUS0% 0.3%
INDUCED ABORTION FAILED0% 0.3%
RUPTURED ECTOPIC PREGNANCY0% 0.3%
INJURY0% 0.3%
STAPHYLOCOCCAL INFECTION0% 0.3%
PREMATURE BABY0% 0.3%
RETAINED PRODUCTS OF CONCEPTION0% 0.2%
GESTATIONAL DIABETES0% 0.2%
PULMONARY EMBOLISM0% 0.2%
RESPIRATORY FAILURE0% 0.2%
STILLBIRTH0% 0.2%

New treatments are found every day. View current AMITIZA research studies and MISOPROSTOL clinical trials

1